(-)-demecolcine increases expression ISO RGD:733858 6480464 Demecolcine results in increased expression of IREB2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:733858 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IREB2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of IREB2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of IREB2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:621539 6480464 Ethinyl Estradiol results in increased expression of IREB2 mRNA CTD PMID:29097150 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IREB2 mRNA, Tetrachlorodibenzodioxin results in decreased expression of IREB2 protein CTD PMID:18163543 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:621539 6480464 Tetrachlorodibenzodioxin results in decreased expression of IREB2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IREB2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to IREB2 gene] CTD PMID:25975270 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IREB2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621539 6480464 Tetrachlorodibenzodioxin affects the expression of IREB2 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression ISO RGD:621539 6480464 2, 4-dinitrotoluene affects the expression of IREB2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:621539 6480464 2, 6-dinitrotoluene affects the expression of IREB2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:733858 6480464 Lactic Acid results in decreased expression of IREB2 mRNA CTD PMID:30851411 4-hydroxy-TEMPO increases expression EXP 6480464 tempol results in increased expression of IREB2 protein CTD PMID:18073202 5-fluorouracil increases expression ISO RGD:733858 6480464 Fluorouracil results in increased expression of IREB2 mRNA CTD PMID:16584549 acrolein multiple interactions ISO RGD:733858 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IREB2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IREB2 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:621539 6480464 Acrylamide results in increased expression of IREB2 mRNA CTD PMID:28959563 aldehydo-D-glucose multiple interactions ISO RGD:621539 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein, Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein] CTD PMID:16135072 all-trans-retinoic acid decreases expression ISO RGD:621539 6480464 Tretinoin results in decreased expression of IREB2 mRNA CTD PMID:22154532 all-trans-retinoic acid multiple interactions ISO RGD:621539 6480464 Ro 41-5253 inhibits the reaction [Tretinoin results in decreased expression of IREB2 mRNA] CTD PMID:22154532 all-trans-retinol increases expression ISO RGD:621539 6480464 Vitamin A deficiency results in increased expression of IREB2 mRNA CTD PMID:22154532 alpha-pinene multiple interactions ISO RGD:733858 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IREB2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IREB2 mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:621539 6480464 Ammonium Chloride affects the expression of IREB2 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:733858 6480464 aristolochic acid I results in decreased expression of IREB2 mRNA CTD PMID:33212167 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of IREB2 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733858 6480464 7 more ... CTD PMID:19150397 bisphenol A affects expression ISO RGD:621539 6480464 bisphenol A affects the expression of IREB2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:733858 6480464 bisphenol A results in increased methylation of IREB2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:621539 6480464 bisphenol A results in increased expression of IREB2 mRNA CTD PMID:34947998 butanal decreases expression ISO RGD:733858 6480464 butyraldehyde results in decreased expression of IREB2 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:733858 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IREB2 mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:621539 6480464 Cadmium Chloride results in decreased expression of IREB2 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:733858 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IREB2 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO RGD:733858 6480464 Caffeine results in decreased phosphorylation of IREB2 protein CTD PMID:35688186 cisplatin multiple interactions ISO RGD:733858 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:33969609 cisplatin decreases expression ISO RGD:733858 6480464 Cisplatin results in decreased expression of IREB2 mRNA, Cisplatin results in decreased expression of IREB2 protein CTD PMID:33969609 clofibrate multiple interactions ISO RGD:621539 6480464 Clofibrate inhibits the reaction [Iron deficiency results in increased activity of IREB2 protein] CTD PMID:11969379 copper atom increases expression ISO RGD:621539 6480464 Copper deficiency results in increased expression of IREB2 mRNA CTD PMID:24024382 copper(0) increases expression ISO RGD:621539 6480464 Copper deficiency results in increased expression of IREB2 mRNA CTD PMID:24024382 cyclosporin A decreases expression ISO RGD:733858 6480464 Cyclosporine results in decreased expression of IREB2 mRNA CTD PMID:25562108 D-glucose multiple interactions ISO RGD:621539 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein, Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein] CTD PMID:16135072 desferrioxamine B increases expression ISO RGD:621539 6480464 Deferoxamine results in increased expression of IREB2 protein CTD PMID:17469137 desferrioxamine B increases activity ISO RGD:733858 6480464 Deferoxamine results in increased activity of IREB2 protein CTD PMID:10397746 desferrioxamine B increases activity ISO RGD:621539 6480464 Deferoxamine results in increased activity of IREB2 protein CTD PMID:16135072 desferrioxamine B increases activity EXP 6480464 Deferoxamine results in increased activity of IREB2 protein CTD PMID:11054110 , PMID:18073202 desferrioxamine B multiple interactions ISO RGD:621539 6480464 Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein], Deferoxamine results in increased expression of and results in increased activity of IREB2 protein CTD PMID:16135072 , PMID:16568477 dioxygen multiple interactions ISO RGD:621539 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein, Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein] CTD PMID:16135072 dioxygen decreases expression ISO RGD:733858 6480464 Oxygen deficiency results in decreased expression of IREB2 mRNA, Oxygen deficiency results in decreased expression of IREB2 protein CTD PMID:33969609 dorsomorphin multiple interactions ISO RGD:733858 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases activity EXP 6480464 Doxorubicin results in decreased activity of IREB2 protein CTD PMID:16770644 doxorubicin decreases activity ISO RGD:621539 6480464 Doxorubicin results in decreased activity of IREB2 protein CTD PMID:11731422 etoposide multiple interactions ISO RGD:733858 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:33969609 etoposide decreases expression ISO RGD:733858 6480464 Etoposide results in decreased expression of IREB2 mRNA, Etoposide results in decreased expression of IREB2 protein CTD PMID:33969609 ferric ammonium citrate decreases expression ISO RGD:621539 6480464 ferric ammonium citrate results in decreased expression of IREB2 protein CTD PMID:17469137 ferric ammonium citrate decreases activity EXP 6480464 ferric ammonium citrate results in decreased activity of IREB2 protein CTD PMID:11054110 , PMID:18073202 finasteride increases expression ISO RGD:621539 6480464 Finasteride results in increased expression of IREB2 mRNA CTD PMID:24136188 flavonoids decreases expression ISO RGD:621539 6480464 Flavonoids results in decreased expression of IREB2 mRNA CTD PMID:18035473 flutamide increases expression ISO RGD:621539 6480464 Flutamide results in increased expression of IREB2 mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:733858 6480464 Formaldehyde results in decreased expression of IREB2 mRNA CTD PMID:20655997 furan increases methylation ISO RGD:621539 6480464 furan results in increased methylation of IREB2 gene CTD PMID:22079235 gentamycin decreases expression ISO RGD:621539 6480464 Gentamicins results in decreased expression of IREB2 mRNA CTD PMID:33387578 glucose multiple interactions ISO RGD:621539 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein, Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein] CTD PMID:16135072 hemin multiple interactions ISO RGD:621539 6480464 Hemin results in decreased expression of and results in decreased activity of IREB2 protein CTD PMID:16568477 iron atom affects metabolic processing EXP 6480464 IREB2 protein affects the metabolism of Iron CTD PMID:17194590 iron atom increases activity ISO RGD:621539 6480464 Iron deficiency results in increased activity of IREB2 protein CTD PMID:11969379 iron atom multiple interactions ISO RGD:621539 6480464 Clofibrate inhibits the reaction [Iron deficiency results in increased activity of IREB2 protein] CTD PMID:11969379 iron(0) increases activity ISO RGD:621539 6480464 Iron deficiency results in increased activity of IREB2 protein CTD PMID:11969379 iron(0) affects metabolic processing EXP 6480464 IREB2 protein affects the metabolism of Iron CTD PMID:17194590 iron(0) multiple interactions ISO RGD:621539 6480464 Clofibrate inhibits the reaction [Iron deficiency results in increased activity of IREB2 protein] CTD PMID:11969379 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with CAT protein] inhibits the reaction [Zinc deficiency results in increased expression of IREB2 protein] CTD PMID:18073202 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with IFNG protein] results in decreased activity of IREB2 protein CTD PMID:11054110 lipopolysaccharide decreases activity EXP 6480464 Lipopolysaccharides results in decreased activity of IREB2 protein CTD PMID:11054110 manganese atom decreases activity ISO RGD:621539 6480464 Manganese results in decreased activity of IREB2 protein CTD PMID:16568477 manganese atom increases expression ISO RGD:621539 6480464 Manganese results in increased expression of IREB2 protein CTD PMID:17469137 manganese(0) decreases activity ISO RGD:621539 6480464 Manganese results in decreased activity of IREB2 protein CTD PMID:16568477 manganese(0) increases expression ISO RGD:621539 6480464 Manganese results in increased expression of IREB2 protein CTD PMID:17469137 manganese(II) chloride decreases activity ISO RGD:621539 6480464 manganese chloride results in decreased activity of IREB2 protein CTD PMID:16568477 manganese(II) chloride increases activity ISO RGD:621539 6480464 manganese chloride results in increased activity of IREB2 protein CTD PMID:15893546 methapyrilene affects expression ISO RGD:733858 6480464 Methapyrilene affects the expression of IREB2 mRNA CTD PMID:28935588 methapyrilene decreases expression ISO RGD:621539 6480464 Methapyrilene results in decreased expression of IREB2 mRNA CTD PMID:30467583 Methylazoxymethanol acetate increases expression ISO RGD:621539 6480464 Methylazoxymethanol Acetate results in increased expression of IREB2 mRNA CTD PMID:28349193 methylmercury chloride decreases expression ISO RGD:733858 6480464 methylmercuric chloride results in decreased expression of IREB2 mRNA CTD PMID:28001369 miconazole decreases expression EXP 6480464 Miconazole results in decreased expression of IREB2 mRNA CTD PMID:27462272 monosodium L-glutamate decreases expression ISO RGD:621539 6480464 Sodium Glutamate results in decreased expression of IREB2 mRNA CTD PMID:20928830 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Zinc deficiency results in increased expression of IREB2 protein] CTD PMID:18073202 nefazodone increases expression ISO RGD:621539 6480464 nefazodone results in increased expression of IREB2 mRNA CTD PMID:24136188 okadaic acid multiple interactions ISO RGD:621539 6480464 Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of IREB2 protein] more ... CTD PMID:10889193 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of IREB2 mRNA CTD PMID:19913091 oxidopamine multiple interactions EXP 6480464 [IREB2 protein affects the susceptibility to Oxidopamine] which results in decreased expression of HEPH mRNA, Oxidopamine promotes the reaction [IREB2 protein results in decreased expression of SLC40A1 mRNA] CTD PMID:19913091 ozone multiple interactions ISO RGD:733858 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IREB2 mRNA more ... CTD PMID:32699268 p-chloromercuribenzoic acid decreases expression ISO RGD:733858 6480464 p-Chloromercuribenzoic Acid results in decreased expression of IREB2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:733858 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IREB2 mRNA CTD PMID:27188386 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of IREB2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:621539 6480464 Acetaminophen results in decreased expression of IREB2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:733858 6480464 Acetaminophen results in decreased expression of IREB2 mRNA CTD PMID:21420995 perfluorooctanoic acid increases expression ISO RGD:621539 6480464 perfluorooctanoic acid results in increased expression of IREB2 mRNA CTD PMID:19162173 phenylmercury acetate decreases expression ISO RGD:733858 6480464 Phenylmercuric Acetate results in decreased expression of IREB2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733858 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IREB2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases activity ISO RGD:621539 6480464 Tetradecanoylphorbol Acetate results in increased activity of IREB2 protein CTD PMID:10889193 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [TRH protein results in increased activity of IREB2 protein] CTD PMID:10889193 phorbol 13-acetate 12-myristate increases activity EXP 6480464 Tetradecanoylphorbol Acetate results in increased activity of IREB2 protein CTD PMID:10889193 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:621539 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of IREB2 protein] more ... CTD PMID:10889193 phorone affects expression ISO RGD:621539 6480464 phorone affects the expression of IREB2 mRNA CTD PMID:18198479 phosphane affects expression ISO RGD:621539 6480464 phosphine affects the expression of IREB2 mRNA CTD PMID:34427094 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of IREB2 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:733858 6480464 potassium chromate(VI) results in decreased expression of IREB2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:733858 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IREB2 mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:733858 6480464 Potassium Dichromate results in increased expression of IREB2 protein CTD PMID:23718831 protein kinase inhibitor multiple interactions EXP 6480464 Protein Kinase Inhibitors inhibits the reaction [TRH protein results in increased activity of IREB2 protein] CTD PMID:10889193 rac-lactic acid decreases expression ISO RGD:733858 6480464 Lactic Acid results in decreased expression of IREB2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:733858 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of IREB2 mRNA CTD PMID:23557933 Ro 41-5253 multiple interactions ISO RGD:621539 6480464 Ro 41-5253 inhibits the reaction [Tretinoin results in decreased expression of IREB2 mRNA] CTD PMID:22154532 SB 431542 multiple interactions ISO RGD:733858 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sunitinib increases expression ISO RGD:733858 6480464 Sunitinib results in increased expression of IREB2 mRNA CTD PMID:31533062 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of IREB2 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:621539 6480464 Carbon Tetrachloride results in increased expression of IREB2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IREB2 mRNA CTD PMID:31919559 thioacetamide increases expression ISO RGD:621539 6480464 Thioacetamide results in increased expression of IREB2 mRNA CTD PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of IREB2 mRNA CTD PMID:19448997 trichloroethene decreases expression ISO RGD:621539 6480464 Trichloroethylene results in decreased expression of IREB2 mRNA CTD PMID:33387578 trichloroethene increases expression ISO RGD:621539 6480464 Trichloroethylene results in increased expression of IREB2 mRNA CTD PMID:19448997 valproic acid decreases expression ISO RGD:733858 6480464 Valproic Acid results in decreased expression of IREB2 mRNA CTD PMID:23179753 valproic acid increases expression ISO RGD:733858 6480464 Valproic Acid results in increased expression of IREB2 mRNA CTD PMID:28001369 valproic acid decreases methylation ISO RGD:733858 6480464 Valproic Acid results in decreased methylation of IREB2 gene CTD PMID:29154799 vinclozolin increases expression ISO RGD:621539 6480464 vinclozolin results in increased expression of IREB2 mRNA CTD PMID:23555832 vincristine increases expression ISO RGD:733858 6480464 Vincristine results in increased expression of IREB2 mRNA CTD PMID:23649840 zinc atom multiple interactions EXP 6480464 [Ascorbic Acid co-treated with CAT protein] inhibits the reaction [Zinc deficiency results in increased expression of IREB2 protein] more ... CTD PMID:18073202 zinc atom increases expression ISO RGD:621539 6480464 Zinc deficiency results in increased expression of IREB2 mRNA CTD PMID:24024381 zinc dichloride increases expression ISO RGD:733858 6480464 zinc chloride results in increased expression of IREB2 mRNA CTD PMID:18947441 zinc(0) multiple interactions EXP 6480464 [Ascorbic Acid co-treated with CAT protein] inhibits the reaction [Zinc deficiency results in increased expression of IREB2 protein] more ... CTD PMID:18073202 zinc(0) increases expression ISO RGD:621539 6480464 Zinc deficiency results in increased expression of IREB2 mRNA CTD PMID:24024381 zoledronic acid increases expression ISO RGD:733858 6480464 zoledronic acid results in increased expression of IREB2 mRNA CTD PMID:20977926